What is ADPT’s calculated intrinsic value vs its market price?
Adaptive Biotechnologies Corporation (ADPT) current market price is $24.66. Tickerplace Pro unlocks the dollar intrinsic value estimate. This is a model output, not a recommendation.
Search companies or stocks...
Adaptive Biotechnologies Corporation (ADPT) valuation snapshot is loading. Our models compare market price to fair value using DCF, P/E, and P/S frameworks.
Confidence score is based on the magnitude of the gap vs the modeled estimate.
Fair value estimate
Unlock fair valueCurrent price
$24.66
Intrinsic value work for Adaptive Biotechnologies Corporation anchors fair value on owner earnings and balance-sheet capacity, then places the current quote next to that estimate.
Versus historical valuation bands, ADPT can sit toward the lower or upper end of where this business has traded when profitability and growth were comparable — useful context before reading any single headline multiple.
Sector peers and macro rates still deserve a sanity check on the company page. The percentage gap on this snapshot is a model output, not a recommendation.
Adaptive Biotechnologies Corporation (ADPT) current market price is $24.66. Tickerplace Pro unlocks the dollar intrinsic value estimate. This is a model output, not a recommendation.
Intrinsic value is an estimate of what ADPT shares may be worth based on fundamentals rather than today's price alone. See the valuation snapshot on this page for the latest model output. Tickerplace Pro unlocks the full dollar fair value estimate.
Tickerplace calculates ADPT's fair value using Discounted Cash Flow (DCF), P/E Multiple, and P/S Multiple models. We compare the resulting intrinsic value estimate to the live market price to show the calculated gap.
The fair value gap is the percentage difference between ADPT’s market price and the modeled fair value estimate. Use it as one research input alongside fundamentals — not as a recommendation.
Peers for ADPT: open their calculated fair value vs price view.